Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Moroni

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Molecular Biosciences|September 12, 2022
A Fe<sup>2+</sup>-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymesLuigi Scietti, Elisabetta Moroni, Daiana Mattoteia, et al.
Journal of Chemical Information and Modeling|October 23, 2024
Design and Test of Molecules that Interfere with the Recognition Mechanisms between the SARS-CoV-2 Spike Protein and Its Host Cell ReceptorsFrancesca Scantamburlo, Ionica Masgras, Francesco Ciscato, et al.
Cell Death & Disease|May 2, 2021
HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxiaClaudio Laquatra, Carlos Sanchez-Martin, Alberto Dinarello, et al.
Journal of Molecular Biology|February 1, 2022
Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical ProbesAlice Triveri, Carlos Sanchez-Martin, Luca Torielli, et al.
Scientific Reports|March 23, 2016
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitorsChiara Foglieni, Katiuscia Pagano, Marco Lessi, et al.
Organic & Biomolecular Chemistry|July 8, 2011
Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus LangerinManuel Andreini, Daniela Doknic, Ieva Sutkeviciute, et al.
Pharmacological Research|April 29, 2026
HIJACKING CLIENT INSTABILITY TO SELECTIVELY DISRUPT HSP90-DRIVEN GLUCOCORTICOID RECEPTOR ACTIVATIONElisa Longhi, Andrea Magni, Luca Torielli, et al.
Cancer Cell|August 13, 2015
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer TherapyRoberto Ronca, Arianna Giacomini, Emanuela Di Salle, et al.
Angiogenesis|September 1, 2018
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)Marco Rusnati, Patrizia Borsotti, Elisabetta Moroni, et al.
Molecular Pharmaceutics|November 22, 2013
Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinomaLaura Gatti, Michelandrea De Cesare, Emilio Ciusani, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Molecular Biosciences|September 12, 2022
A Fe<sup>2+</sup>-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymesLuigi Scietti, Elisabetta Moroni, Daiana Mattoteia, et al.
Journal of Chemical Information and Modeling|October 23, 2024
Design and Test of Molecules that Interfere with the Recognition Mechanisms between the SARS-CoV-2 Spike Protein and Its Host Cell ReceptorsFrancesca Scantamburlo, Ionica Masgras, Francesco Ciscato, et al.
Cell Death & Disease|May 2, 2021
HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxiaClaudio Laquatra, Carlos Sanchez-Martin, Alberto Dinarello, et al.
Journal of Molecular Biology|February 1, 2022
Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical ProbesAlice Triveri, Carlos Sanchez-Martin, Luca Torielli, et al.
Scientific Reports|March 23, 2016
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitorsChiara Foglieni, Katiuscia Pagano, Marco Lessi, et al.
Organic & Biomolecular Chemistry|July 8, 2011
Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus LangerinManuel Andreini, Daniela Doknic, Ieva Sutkeviciute, et al.
Pharmacological Research|April 29, 2026
HIJACKING CLIENT INSTABILITY TO SELECTIVELY DISRUPT HSP90-DRIVEN GLUCOCORTICOID RECEPTOR ACTIVATIONElisa Longhi, Andrea Magni, Luca Torielli, et al.
Cancer Cell|August 13, 2015
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer TherapyRoberto Ronca, Arianna Giacomini, Emanuela Di Salle, et al.
Angiogenesis|September 1, 2018
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)Marco Rusnati, Patrizia Borsotti, Elisabetta Moroni, et al.
Molecular Pharmaceutics|November 22, 2013
Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinomaLaura Gatti, Michelandrea De Cesare, Emilio Ciusani, et al.
Pageof 7